Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Background. Atrial fibrillation (AF) is the most common serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality in general population. Hypertension is the most prevalent and potentially modifiable risk factor for AF. This study is aimed at evaluating the effect...

Descripció completa

Dades bibliogràfiques
Autors principals:	Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan
Format:	Article
Idioma:	English
Publicat:	Hindawi-Wiley 2021-01-01
Col·lecció:	Cardiovascular Therapeutics
Accés en línia:	http://dx.doi.org/10.1155/2021/6628469

Ítems similars

Angiotensin&nbsp;II receptor blockers in the prevention of complications from atrial fibrillation
per: Gerald V Naccarelli, et al.
Publicat: (2009-09-01)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
per: Cesare Cuspidi, et al.
Publicat: (2008-02-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
per: Ji-Guang Wang
Publicat: (2009-07-01)

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
per: Jun Kishihara, et al.
Publicat: (2012-02-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
per: E. V. Kokhan, et al.
Publicat: (2021-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
per: O. M. Drapkina, et al.
Publicat: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
per: O. M. Drapkina, et al.
Publicat: (2014-07-01)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
per: Weiss Michael J, et al.
Publicat: (2010-02-01)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
per: Gorav Batra, et al.
Publicat: (2017-03-01)

Termination of Aconitine-Induced Atrial Fibrillation by the KACh-Channel Blocker Tertiapin: Underlying Electrophysiological Mechanism
per: Kazumasa Suzuki, et al.
Publicat: (2014-01-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
per: Nicole Habel, et al.
Publicat: (2023-06-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
per: Antonio Eduardo Pesaro, et al.
Publicat: (2010-01-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
per: Eiichiro Yamamoto, et al.
Publicat: (2012-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
per: Tadafumi Nanbu, et al.
Publicat: (2023-06-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
per: Hyun Woong Lee
Publicat: (2014-12-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
Publicat: (2013-01-01)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
per: Nishida Yayoi, et al.
Publicat: (2012-05-01)

The haemodynamic changes associated with treatment of new-onset atrial fibrillation with amiodarone or beta blockers
per: Bedford, J, et al.
Publicat: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
per: Yanhua Yang, et al.
Publicat: (2020-01-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
per: Athanasios Kartalis, et al.
Publicat: (2024-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
per: Mohamed Zeinah, et al.
Publicat: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
per: Hebah Hassan, BS, et al.
Publicat: (2020-06-01)

The use of angiotensin receptor blockers in dementia prevention
per: Jordana de Araujo Müller, et al.
Publicat: (2023-09-01)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
per: Tianyu Zhu, et al.
Publicat: (2022-12-01)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis
per: Kotecha, D, et al.
Publicat: (2014)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
per: Kotecha, D, et al.
Publicat: (2014)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
per: Akif Arslan, et al.
Publicat: (2016-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
per: Mina Mohammed, et al.
Publicat: (2024-06-01)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
per: Yen-Chung Lin, et al.
Publicat: (2017-01-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
per: O. V. Dralova, et al.
Publicat: (2016-01-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
per: O. D. Ostroumova, et al.
Publicat: (2016-12-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
per: Tianyu Xu, et al.
Publicat: (2019-06-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
per: M. A. Maksimova, et al.
Publicat: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
per: M. A. Maksimova, et al.
Publicat: (2015-09-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
per: Huijin Lee, et al.
Publicat: (2024-10-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
per: Volpe M, et al.
Publicat: (2012-06-01)

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial)
per: Kenichiro Kinouchi, et al.
Publicat: (2011-01-01)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
per: Han Saem Jeong, et al.
Publicat: (2021-01-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
per: Youzheng Dong, et al.
Publicat: (2022-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
per: Kenji Yamamoto, et al.
Publicat: (2023-04-01)